LDX lumos diagnostics holdings limited

0.00%

2.9¢

thank you for sharing this. Your efforts are much appreciated.

First 29 Last

Share
Profile

Follow
energyraters

1,420 Posts.

269

07/05/24

07:59

Post #: 73695532
Share

Originally posted by FindMyBroker: ↑

I received some communication some time ago in respect of queries around the Hologic deal and FFN product. Here are the responses for interpretation:
Response 1 to a query I had:
This has really laid the foundations for long term revenue from conducting the next phases of the product development program, long term manufacturing contracts, new tests to add menu items (tests) to the reader that Hologic place in customer sites, and expansion of the IP agreement to provide an exclusive licence for the addition indications covered by the new menu items. Very frustrating that the market seems to have missed the significance of this. I guess we just have to keep working at communicating it better.

Response 2 to a query I had:
In terms of margins on sales, I believe that Lumos will not be paid any kind of royalty but will make money from a manufacturing margin for supplying the finished product that is sold. Worth noting, when a device is approved, it includes the place of manufacture so there is a real switching barrier which is why these medical device manufacturing contracts are so valuable - effectively annuity income.

I would guess (and this is a guess) that would be around 15-20% of the wholesale price which is typically 60% of the retail price. So if you worked off 7.5%-10% of sales, you should be in the ballpark. But this is a guess (educated guess but still a guess).I think people need to understand that the device for Hologic is built on the foundation of the Leelu reader and is expanded upon existing technology Hologic already use. They will likely incorporate further tests into the second generation platform for Hologic to use, hence the amount in the initial IP payment.

I would suggest that ongoing annuities from the platform will be generated and further development work obtains when new tests are established through the Leelu reader.

Febridx can be used through the Leelu reader also.

Expand

thank you for sharing this. Your efforts are much appreciated.

LDX Price at posting: 5.3¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

PIQ

Proteomics notches up as company launches PromarkerD into the US

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

First 29 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.9¢		Change 0.000(0.00%)		Mkt cap ! $21.70M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.9¢	$1.912K	65.93K

Buyers (Bids)

No.	Vol.	Price($)
4	571666	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	150000	1

View Market Depth

No.	Vol.	Price($)
4	571666	0.028
3	318288	0.027
2	443000	0.026
6	601153	0.025
1	1238229	0.024

Price($)	Vol.	No.
0.030	150000	1
0.031	250309	3
0.032	51725	1
0.033	190000	1
0.034	189253	1

Last trade - 10.42am 20/06/2025 (20 minute delay)

LDX (ASX) Chart

thank you for sharing this. Your efforts are much appreciated.

Proteomics notches up as company launches PromarkerD into the US

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

thank you for sharing this. Your efforts are much appreciated.

Top Stories

Proteomics notches up as company launches PromarkerD into the US

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News